GH Axis
Tesamorelin
TH9507 · Egrifta
Stabilised GHRH analogue with phase 3 evidence for visceral-fat reduction.
2 mg5 mg10 mg15 mg20 mg
Tesamorelin + Ipamorelin
Also known as: Tesa/Ipa blend
Growth Hormone Axis Blend In stock Box of 10 vials 2 references
Stabilised GHRH analogue paired with the selective GHS-R agonist.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| TIP10 | 10 mg (5 + 5) | 10 vials / box | |
| TIP20 | 20 mg (10 + 10) | 10 vials / box |
Order Tesamorelin + Ipamorelin
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
A 1:1 co-formulation of tesamorelin and ipamorelin. Tesamorelin provides DPP-4-resistant GHRH-receptor stimulation with phase 3 visceral-fat data 1; ipamorelin provides selective ghrelin-receptor stimulation without cortisol or prolactin release 2. Supplied as 5 + 5 mg or 10 + 10 mg.
At a glance
- 1:1 tesamorelin : ipamorelin
- 10 mg or 20 mg total per vial
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-70.
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.
Related
Often ordered together
GH Axis
Ipamorelin
NNC 26-0161 · Selective GH secretagogue
The first selective growth-hormone secretagogue — GH release without cortisol or prolactin.
5 mg10 mg
GH Axis Blend
CJC-1295 (No DAC) + Ipamorelin
CJC/Ipa blend · GHRH + GHRP stack
GHRH analogue plus selective secretagogue — the classic synergistic GH-release pairing.
10 mg (5 + 5)